Biotechnology
The Biotechnology industry has a total of 623 stocks, with a combined market cap of $915.69 billion and total revenue of $101.52 billion.
Market Cap
915.69B
Revenue
101.52B
Profits
-42.56B
PE Ratio
n/a
Profit Margin
-41.92%
Dividend Yield
0.05%
623 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 99.26B | -1.08% | 2,040,877 | 11.42B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 60.71B | 1.82% | 921,289 | 14.21B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 59.21B | -2.06% | 1,445,458 | 2.46B |
| 4 | ARGX | argenx SE | 45.48B | -2.39% | 377,813 | 3.12B |
| 5 | ONC | BeOne Medicines AG | 36.57B | 1.53% | 157,796 | 4.56B |
| 6 | INSM | Insmed Incorporated | 30.60B | 0.02% | 1,728,088 | 398.11M |
| 7 | BNTX | BioNTech SE | 23.60B | -1.12% | 1,033,793 | 3.38B |
| 8 | RPRX | Royalty Pharma plc | 20.78B | 0.62% | 9,027,060 | 2.31B |
| 9 | GMAB | Genmab A/S | 17.29B | -0.57% | 1,487,845 | 3.65B |
| 10 | INCY | Incyte Corporation | 16.56B | 1.07% | 1,581,997 | 4.58B |
| 11 | SMMT | Summit Therapeutics Inc. | 13.44B | -0.17% | 5,527,868 | - |
| 12 | ASND | Ascendis Pharma A/S | 12.09B | 1.19% | 254,687 | 576.33M |
| 13 | EXEL | Exelixis, Inc. | 10.89B | 3.32% | 2,664,045 | 2.23B |
| 14 | BMRN | BioMarin Pharmaceutical Inc. | 10.44B | 0.80% | 2,705,710 | 3.06B |
| 15 | ROIV | Roivant Sciences Ltd. | 10.43B | 7.76% | 26,930,137 | 23.23M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 9.78B | -0.60% | 1,814,432 | 235.81M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 9.75B | -0.24% | 1,636,337 | 944.05M |
| 18 | MRNA | Moderna, Inc. | 9.73B | 0.64% | 13,335,829 | 3.08B |
| 19 | CAI | Caris Life Sciences, Inc. | 9.43B | -0.39% | 571,813 | 533.85M |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.30B | -2.25% | 286,029 | 515.55M |
| 21 | VRNA | Verona Pharma plc | 9.16B | 0.02% | 3,194,806 | 221.67M |
| 22 | HALO | Halozyme Therapeutics, Inc. | 8.87B | -0.05% | 1,469,916 | 1.18B |
| 23 | RVMD | Revolution Medicines, Inc. | 8.19B | -1.99% | 2,472,318 | - |
| 24 | TECH | Bio-Techne Corporation | 8.01B | -0.50% | 1,819,529 | 1.22B |
| 25 | CORT | Corcept Therapeutics Incorporated | 7.92B | 5.41% | 1,114,354 | 716.08M |
| 26 | JAZZ | Jazz Pharmaceuticals plc | 7.86B | 2.37% | 738,742 | 4.09B |
| 27 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.38B | 0.61% | 716,942 | 156.29M |
| 28 | LEGN | Legend Biotech Corporation | 6.36B | 0.38% | 1,120,883 | 796.84M |
| 29 | ABVX | ABIVAX Société Anonyme | 6.21B | -1.56% | 775,053 | 7.07M |
| 30 | AXSM | Axsome Therapeutics, Inc. | 5.82B | 2.21% | 592,045 | 495.03M |
| 31 | RNA | Avidity Biosciences, Inc. | 5.75B | -3.33% | 2,732,821 | 10.73M |
| 32 | CYTK | Cytokinetics, Incorporated | 5.69B | -4.42% | 7,458,051 | 85.74M |
| 33 | NUVL | Nuvalent, Inc. | 5.67B | 0.40% | 308,612 | - |
| 34 | CRSP | CRISPR Therapeutics AG | 5.37B | -3.46% | 2,767,906 | 38.05M |
| 35 | MRUS | Merus N.V. | 5.16B | 1.91% | 682,672 | 56.23M |
| 36 | PTCT | PTC Therapeutics, Inc. | 4.82B | 1.61% | 2,262,520 | 1.76B |
| 37 | TGTX | TG Therapeutics, Inc. | 4.67B | 0.16% | 2,126,843 | 454.07M |
| 38 | KRYS | Krystal Biotech, Inc. | 4.46B | -0.21% | 280,169 | 359.21M |
| 39 | ACLX | Arcellx, Inc. | 4.24B | -1.20% | 506,655 | 56.98M |
| 40 | ACAD | ACADIA Pharmaceuticals Inc. | 4.08B | 1.00% | 1,617,755 | 1.02B |
| 41 | ARWR | Arrowhead Pharmaceuticals, Inc. | 4.03B | -0.99% | 1,873,433 | 572.98M |
| 42 | PCVX | Vaxcyte, Inc. | 4.01B | -1.10% | 2,957,574 | - |
| 43 | ADMA | ADMA Biologics, Inc. | 3.71B | -0.83% | 2,677,971 | 474.17M |
| 44 | PTGX | Protagonist Therapeutics, Inc. | 3.68B | 1.08% | 912,616 | 209.18M |
| 45 | MIRM | Mirum Pharmaceuticals, Inc. | 3.67B | -0.88% | 606,883 | 429.16M |
| 46 | ZLAB | Zai Lab Limited | 3.63B | 0.87% | 284,332 | 427.80M |
| 47 | AAPG | Ascentage Pharma Group International | 3.59B | -0.66% | 5,936 | 54.52M |
| 48 | MTSR | Metsera, Inc. | 3.45B | -1.23% | 2,742,536 | - |
| 49 | KYMR | Kymera Therapeutics, Inc. | 3.44B | -1.35% | 1,365,377 | 44.71M |
| 50 | AKRO | Akero Therapeutics, Inc. | 3.37B | -0.99% | 1,187,968 | - |
| 51 | MLTX | MoonLake Immunotherapeutics | 3.25B | -3.91% | 1,372,023 | - |
| 52 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.22B | 0.29% | 841,873 | 1.39M |
| 53 | TLX | Telix Pharmaceuticals Limited | 3.14B | -0.42% | 81,136 | 664.23M |
| 54 | SRRK | Scholar Rock Holding Corporation | 3.07B | -1.21% | 1,840,301 | - |
| 55 | CNTA | Centessa Pharmaceuticals plc | 2.93B | 2.44% | 1,406,100 | 15.00M |
| 56 | APLS | Apellis Pharmaceuticals, Inc. | 2.92B | -2.90% | 2,181,761 | 754.65M |
| 57 | MLYS | Mineralys Therapeutics, Inc. | 2.89B | -0.35% | 1,473,163 | - |
| 58 | CGON | CG Oncology, Inc. | 2.88B | 5.48% | 2,240,941 | 551.00K |
| 59 | XENE | Xenon Pharmaceuticals Inc. | 2.83B | 2.92% | 928,529 | 7.50M |
| 60 | RARE | Ultragenyx Pharmaceutical Inc. | 2.76B | -2.61% | 1,366,577 | 610.16M |
| 61 | NAMS | NewAmsterdam Pharma Company N.V. | 2.76B | -0.12% | 509,302 | 64.01M |
| 62 | SLNO | Soleno Therapeutics, Inc. | 2.71B | 2.55% | 2,108,637 | 32.66M |
| 63 | IMVT | Immunovant, Inc. | 2.63B | -1.18% | 1,358,864 | - |
| 64 | IBRX | ImmunityBio, Inc. | 2.61B | -1.78% | 11,659,293 | 56.60M |
| 65 | VKTX | Viking Therapeutics, Inc. | 2.60B | -2.53% | 5,021,929 | - |
| 66 | FOLD | Amicus Therapeutics, Inc. | 2.46B | -0.50% | 4,990,783 | 571.16M |
| 67 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.45B | -0.25% | 987,152 | 558.50M |
| 68 | BLTE | Belite Bio, Inc | 2.40B | 9.12% | 64,617 | - |
| 69 | CELC | Celcuity Inc. | 2.32B | 2.88% | 806,710 | - |
| 70 | BEAM | Beam Therapeutics Inc. | 2.21B | -2.01% | 3,424,971 | 60.27M |
| 71 | APGE | Apogee Therapeutics, Inc. | 2.20B | 2.14% | 446,667 | - |
| 72 | TARS | Tarsus Pharmaceuticals, Inc. | 2.18B | 2.15% | 1,077,012 | 295.52M |
| 73 | LQDA | Liquidia Corporation | 2.15B | -3.96% | 2,318,312 | 19.32M |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 2.14B | -1.13% | 682,786 | 7.00M |
| 75 | IRON | Disc Medicine, Inc. | 2.12B | 1.14% | 418,248 | - |
| 76 | OCUL | Ocular Therapeutix, Inc. | 2.12B | -2.21% | 2,039,924 | 56.66M |
| 77 | AGIO | Agios Pharmaceuticals, Inc. | 2.12B | -0.82% | 621,418 | 40.88M |
| 78 | GLPG | Galapagos NV | 2.11B | 0.75% | 121,809 | 323.67M |
| 79 | TVTX | Travere Therapeutics, Inc. | 2.11B | 3.86% | 2,012,765 | 333.87M |
| 80 | RXRX | Recursion Pharmaceuticals, Inc. | 2.06B | -2.69% | 28,406,238 | 64.60M |
| 81 | ARQT | Arcutis Biotherapeutics, Inc. | 2.06B | 1.00% | 1,411,894 | 263.47M |
| 82 | MESO | Mesoblast Limited | 1.96B | -3.40% | 182,163 | 17.20M |
| 83 | ADPT | Adaptive Biotechnologies Corporation | 1.95B | -0.70% | 1,433,921 | 205.22M |
| 84 | DNLI | Denali Therapeutics Inc. | 1.91B | -1.51% | 2,275,419 | - |
| 85 | DYN | Dyne Therapeutics, Inc. | 1.87B | 1.23% | 1,823,372 | - |
| 86 | HRMY | Harmony Biosciences Holdings, Inc. | 1.84B | -0.71% | 513,350 | 772.53M |
| 87 | PHVS | Pharvaris N.V. | 1.74B | 1.13% | 637,756 | - |
| 88 | COGT | Cogent Biosciences, Inc. | 1.73B | -1.44% | 1,536,179 | - |
| 89 | IMCR | Immunocore Holdings plc | 1.68B | -1.17% | 553,885 | 356.15M |
| 90 | SRPT | Sarepta Therapeutics, Inc. | 1.67B | -5.80% | 6,582,986 | 2.48B |
| 91 | MNKD | MannKind Corporation | 1.65B | 0.37% | 2,579,379 | 301.74M |
| 92 | CDTX | Cidara Therapeutics, Inc. | 1.64B | 0.22% | 611,659 | 302.00K |
| 93 | CLDX | Celldex Therapeutics, Inc. | 1.62B | -0.49% | 1,247,148 | 5.79M |
| 94 | AUPH | Aurinia Pharmaceuticals Inc. | 1.62B | -1.76% | 1,143,434 | 260.11M |
| 95 | VERA | Vera Therapeutics, Inc. | 1.57B | -0.89% | 1,607,735 | - |
| 96 | BHVN | Biohaven Ltd. | 1.56B | 8.97% | 4,293,768 | - |
| 97 | VRDN | Viridian Therapeutics, Inc. | 1.52B | -0.21% | 421,191 | 305.00K |
| 98 | VCEL | Vericel Corporation | 1.51B | -9.66% | 1,683,462 | 249.12M |
| 99 | DNTH | Dianthus Therapeutics, Inc. | 1.50B | 3.76% | 620,593 | 4.85M |
| 100 | ARDX | Ardelyx, Inc. | 1.49B | -3.58% | 2,876,276 | 386.15M |
| 101 | EWTX | Edgewise Therapeutics, Inc. | 1.46B | -1.21% | 651,038 | - |
| 102 | JANX | Janux Therapeutics, Inc. | 1.41B | 0.21% | 545,754 | 439.00K |
| 103 | ABCL | AbCellera Biologics Inc. | 1.37B | -4.19% | 4,752,483 | 32.88M |
| 104 | NVAX | Novavax, Inc. | 1.36B | -1.99% | 4,689,888 | 1.08B |
| 105 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.36B | 6.77% | 2,281,545 | -249.00K |
| 106 | NTLA | Intellia Therapeutics, Inc. | 1.33B | 1.14% | 6,874,412 | 52.86M |
| 107 | YDES | YD Bio Limited | 1.29B | 7.92% | 45,528 | 510.36K |
| 108 | RCUS | Arcus Biosciences, Inc. | 1.28B | 2.38% | 807,954 | 262.00M |
| 109 | SNDX | Syndax Pharmaceuticals, Inc. | 1.27B | -1.93% | 1,491,897 | 77.93M |
| 110 | GPCR | Structure Therapeutics Inc. | 1.25B | -0.64% | 1,382,918 | - |
| 111 | STOK | Stoke Therapeutics, Inc. | 1.25B | -1.81% | 939,622 | 199.89M |
| 112 | XERS | Xeris Biopharma Holdings, Inc. | 1.24B | 2.68% | 1,645,672 | 246.03M |
| 113 | TRML | Tourmaline Bio, Inc. | 1.23B | -0.02% | 1,726,452 | - |
| 114 | INVA | Innoviva, Inc. | 1.22B | 0.21% | 411,412 | 370.23M |
| 115 | RAPP | Rapport Therapeutics, Inc. | 1.21B | 0.42% | 766,264 | - |
| 116 | CVAC | CureVac N.V. | 1.21B | 0.19% | 477,373 | 599.54M |
| 117 | LENZ | LENZ Therapeutics, Inc. | 1.20B | 2.28% | 376,364 | 5.00M |
| 118 | ETNB | 89bio, Inc. | 1.20B | 1.38% | 1,521,241 | - |
| 119 | ZYME | Zymeworks Inc. | 1.19B | 0.19% | 531,307 | 122.87M |
| 120 | PGEN | Precigen, Inc. | 1.14B | -1.80% | 3,513,483 | 4.34M |
| 121 | ELVN | Enliven Therapeutics, Inc. | 1.13B | 3.20% | 560,706 | - |
| 122 | NUVB | Nuvation Bio Inc. | 1.12B | -0.31% | 4,953,564 | 14.36M |
| 123 | WVE | Wave Life Sciences Ltd. | 1.08B | -0.29% | 1,245,174 | 93.95M |
| 124 | MAZE | Maze Therapeutics, Inc. | 1.03B | 0.17% | 437,472 | 2.50M |
| 125 | MDXG | MiMedx Group, Inc. | 1.03B | -0.43% | 572,223 | 363.77M |
| 126 | ORIC | ORIC Pharmaceuticals, Inc. | 1.02B | -3.49% | 1,195,598 | - |
| 127 | ATAI | Atai Life Sciences N.V. | 988.10M | -0.86% | 2,943,735 | 2.31M |
| 128 | PHAR | Pharming Group N.V. | 985.63M | 5.04% | 11,193 | 339.84M |
| 129 | SION | Sionna Therapeutics, Inc. | 980.79M | -4.51% | 252,700 | - |
| 130 | TRVI | Trevi Therapeutics, Inc. | 971.78M | 0.25% | 1,154,990 | - |
| 131 | NKTR | Nektar Therapeutics | 971.28M | 2.37% | 1,353,190 | 74.93M |
| 132 | QURE | uniQure N.V. | 964.32M | -2.14% | 1,450,891 | 14.34M |
| 133 | SPRY | ARS Pharmaceuticals, Inc. | 945.77M | 1.70% | 1,764,272 | 112.34M |
| 134 | EYPT | EyePoint Pharmaceuticals, Inc. | 940.17M | 0.29% | 945,369 | 51.90M |
| 135 | FTRE | Fortrea Holdings Inc. | 936.15M | 2.49% | 1,158,498 | 2.73B |
| 136 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 932.80M | 8.01% | 379,315 | - |
| 137 | PRAX | Praxis Precision Medicines, Inc. | 926.81M | 4.83% | 463,707 | 7.77M |
| 138 | OCS | Oculis Holding AG | 910.64M | -1.47% | 29,356 | 960.67K |
| 139 | SYRE | Spyre Therapeutics, Inc. | 909.03M | 1.55% | 777,281 | - |
| 140 | CRMD | CorMedix Inc. | 868.01M | -4.06% | 4,042,051 | 121.48M |
| 141 | UPB | Upstream Bio, Inc. | 863.63M | -7.67% | 540,214 | 2.72M |
| 142 | VALN | Valneva SE | 854.68M | 12.27% | 116,019 | 230.57M |
| 143 | ABUS | Arbutus Biopharma Corporation | 849.23M | 0.68% | 1,083,584 | 15.42M |
| 144 | TNGX | Tango Therapeutics, Inc. | 847.80M | 3.67% | 4,108,140 | 24.30M |
| 145 | URGN | UroGen Pharma Ltd. | 837.38M | 0.17% | 1,355,393 | 94.24M |
| 146 | GERN | Geron Corporation | 810.28M | 1.60% | 6,399,044 | 164.45M |
| 147 | IOVA | Iovance Biotherapeutics, Inc. | 803.32M | -3.48% | 9,064,894 | 241.53M |
| 148 | ZBIO | Zenas BioPharma, Inc. | 802.83M | 4.52% | 154,233 | 15.00M |
| 149 | SANA | Sana Biotechnology, Inc. | 796.66M | -1.94% | 2,676,886 | - |
| 150 | TSHA | Taysha Gene Therapies, Inc. | 791.11M | 2.11% | 3,556,486 | 8.10M |
| 151 | IMNM | Immunome, Inc. | 782.53M | -1.10% | 1,162,146 | 12.59M |
| 152 | GHRS | GH Research PLC | 775.37M | -1.03% | 106,627 | - |
| 153 | NAGE | Niagen Bioscience, Inc. | 769.63M | 1.48% | 652,937 | 116.30M |
| 154 | PHAT | Phathom Pharmaceuticals, Inc. | 766.13M | 0.18% | 1,760,830 | 114.04M |
| 155 | SVRA | Savara Inc. | 758.48M | -0.83% | 777,204 | - |
| 156 | AVXL | Anavex Life Sciences Corp. | 754.15M | -2.01% | 730,990 | - |
| 157 | PROK | ProKidney Corp. | 744.53M | -3.44% | 1,760,784 | 527.00K |
| 158 | IMTX | Immatics N.V. | 733.00M | 0.50% | 535,805 | 152.82M |
| 159 | MNMD | Mind Medicine (MindMed) Inc. | 728.16M | -1.44% | 1,404,632 | - |
| 160 | IVA | Inventiva S.A. | 722.81M | -0.77% | 31,787 | 14.59M |
| 161 | MRVI | Maravai LifeSciences Holdings, Inc. | 717.57M | -2.77% | 1,610,110 | 219.83M |
| 162 | DAWN | Day One Biopharmaceuticals, Inc. | 716.51M | -1.62% | 948,527 | 187.64M |
| 163 | AVBP | ArriVent BioPharma, Inc. | 710.36M | -3.79% | 311,020 | - |
| 164 | TBPH | Theravance Biopharma, Inc. | 707.58M | 1.30% | 304,649 | 77.21M |
| 165 | RLAY | Relay Therapeutics, Inc. | 705.16M | -0.97% | 1,181,715 | 8.36M |
| 166 | KURA | Kura Oncology, Inc. | 702.19M | -3.11% | 1,336,800 | 83.28M |
| 167 | GYRE | Gyre Therapeutics, Inc. | 684.83M | -0.66% | 59,132 | 102.19M |
| 168 | GOSS | Gossamer Bio, Inc. | 679.87M | -6.56% | 4,804,876 | 40.24M |
| 169 | KALV | KalVista Pharmaceuticals, Inc. | 676.00M | -0.89% | 606,197 | 1.43M |
| 170 | RZLT | Rezolute, Inc. | 670.74M | -0.13% | 997,326 | - |
| 171 | VIR | Vir Biotechnology, Inc. | 666.80M | -1.23% | 783,884 | 19.00M |
| 172 | XNCR | Xencor, Inc. | 659.74M | 7.31% | 1,645,769 | 146.93M |
| 173 | NRIX | Nurix Therapeutics, Inc. | 655.17M | 1.54% | 1,323,543 | 88.38M |
| 174 | TERN | Terns Pharmaceuticals, Inc. | 647.58M | 1.37% | 811,622 | - |
| 175 | TYRA | Tyra Biosciences, Inc. | 647.56M | -1.70% | 276,683 | - |
| 176 | SEPN | Septerna, Inc. | 641.58M | -0.35% | 186,358 | 726.00K |
| 177 | KROS | Keros Therapeutics, Inc. | 634.41M | -1.14% | 197,871 | 232.84M |
| 178 | PVLA | Palvella Therapeutics, Inc. | 625.65M | 3.78% | 238,892 | - |
| 179 | RIGL | Rigel Pharmaceuticals, Inc. | 613.82M | -2.17% | 447,615 | 267.92M |
| 180 | DNA | Ginkgo Bioworks Holdings, Inc. | 613.56M | 4.14% | 1,736,834 | 230.82M |
| 181 | PRME | Prime Medicine, Inc. | 609.62M | -0.43% | 4,044,777 | 4.96M |
| 182 | ORKA | Oruka Therapeutics, Inc. | 607.08M | 8.79% | 1,799,104 | - |
| 183 | CMPX | Compass Therapeutics, Inc. | 602.22M | -2.77% | 807,146 | 850.00K |
| 184 | BCAX | Bicara Therapeutics Inc. | 598.55M | -2.40% | 261,548 | - |
| 185 | MGTX | MeiraGTx Holdings plc | 589.68M | 0.14% | 331,377 | 37.92M |
| 186 | VSTM | Verastem, Inc. | 580.99M | 3.40% | 2,005,203 | 2.14M |
| 187 | ARVN | Arvinas, Inc. | 558.71M | -0.39% | 2,231,971 | 372.80M |
| 188 | ANAB | AnaptysBio, Inc. | 554.62M | 2.11% | 718,272 | 123.16M |
| 189 | OLMA | Olema Pharmaceuticals, Inc. | 531.92M | -1.77% | 694,957 | - |
| 190 | NBTX | Nanobiotix S.A. | 517.63M | 4.75% | 432,714 | -7.44M |
| 191 | ARCT | Arcturus Therapeutics Holdings Inc. | 490.14M | -0.22% | 582,301 | 122.12M |
| 192 | KOD | Kodiak Sciences Inc. | 485.40M | -1.29% | 228,062 | - |
| 193 | BCYC | Bicycle Therapeutics plc | 479.60M | -0.43% | 262,644 | 19.28M |
| 194 | ERAS | Erasca, Inc. | 473.73M | -2.34% | 1,038,234 | - |
| 195 | OPT | Opthea Limited | 466.57M | - | - | 146.00K |
| 196 | RGNX | REGENXBIO Inc. | 456.14M | -2.48% | 295,861 | 155.78M |
| 197 | REPL | Replimune Group, Inc. | 445.70M | -1.38% | 2,256,240 | - |
| 198 | XOMA | XOMA Royalty Corporation | 444.10M | -0.94% | 52,102 | 44.95M |
| 199 | PRTA | Prothena Corporation plc | 433.87M | -1.23% | 507,464 | 10.34M |
| 200 | CRVS | Corvus Pharmaceuticals, Inc. | 431.44M | 0.87% | 414,544 | - |
| 201 | ALMS | Alumis Inc. | 429.79M | -0.72% | 357,267 | 20.06M |
| 202 | SLDB | Solid Biosciences Inc. | 425.94M | 1.11% | 844,573 | - |
| 203 | IMAB | I-Mab | 424.79M | -0.81% | 1,501,733 | 569.46K |
| 204 | ATXS | Astria Therapeutics, Inc. | 417.05M | 1.65% | 512,783 | - |
| 205 | OCGN | Ocugen, Inc. | 412.24M | 12.82% | 8,919,442 | 4.75M |
| 206 | ZVRA | Zevra Therapeutics, Inc. | 411.47M | 0.96% | 1,892,308 | 62.02M |
| 207 | MNPR | Monopar Therapeutics Inc. | 411.17M | 16.91% | 126,612 | - |
| 208 | LXRX | Lexicon Pharmaceuticals, Inc. | 396.10M | -0.91% | 2,093,242 | 58.43M |
| 209 | FULC | Fulcrum Therapeutics, Inc. | 395.95M | 0.27% | 264,209 | 80.00M |
| 210 | GLUE | Monte Rosa Therapeutics, Inc. | 392.79M | -1.70% | 1,928,417 | 177.99M |
| 211 | INBX | Inhibrx Biosciences, Inc. | 384.37M | -0.13% | 105,537 | 1.40M |
| 212 | ABSI | Absci Corporation | 381.28M | -5.56% | 4,023,777 | 4.14M |
| 213 | AURA | Aura Biosciences, Inc. | 378.93M | -3.02% | 246,134 | - |
| 214 | ETHZ | ETHZilla Corporation | 376.54M | -0.87% | 10,240,599 | - |
| 215 | TVRD | Tvardi Therapeutics, Inc. | 366.09M | 15.40% | 134,742 | - |
| 216 | LBRX | LB Pharmaceuticals Inc | 366.05M | 3.36% | 163,899 | - |
| 217 | ADCT | ADC Therapeutics SA | 365.62M | -1.81% | 421,264 | 77.25M |
| 218 | BNTC | Benitec Biopharma Inc. | 359.63M | -1.58% | 57,432 | - |
| 219 | DMAC | DiaMedica Therapeutics Inc. | 355.10M | -1.43% | 392,024 | - |
| 220 | PRTC | PureTech Health plc | 353.30M | 0.61% | 12,462 | 6.39M |
| 221 | CGEM | Cullinan Therapeutics, Inc. | 350.31M | -5.72% | 474,896 | - |
| 222 | LRMR | Larimar Therapeutics, Inc. | 349.21M | 2.00% | 1,532,728 | - |
| 223 | DRUG | Bright Minds Biosciences Inc. | 348.85M | -1.65% | 25,828 | - |
| 224 | CTNM | Contineum Therapeutics, Inc. | 347.44M | 4.29% | 232,343 | - |
| 225 | DSGN | Design Therapeutics, Inc. | 338.84M | 1.71% | 197,807 | - |
| 226 | AUTL | Autolus Therapeutics plc | 338.00M | -3.79% | 3,383,918 | 29.93M |
| 227 | IMRX | Immuneering Corporation | 335.47M | -2.89% | 510,032 | - |
| 228 | MBX | MBX Biosciences, Inc. | 333.92M | 1.95% | 639,673 | - |
| 229 | ENGN | enGene Holdings Inc. | 333.21M | 7.41% | 597,859 | - |
| 230 | RCKT | Rocket Pharmaceuticals, Inc. | 326.95M | -6.77% | 2,630,225 | - |
| 231 | DRTS | Alpha Tau Medical Ltd. | 326.57M | -0.52% | 39,748 | - |
| 232 | ASMB | Assembly Biosciences, Inc. | 320.85M | 0.34% | 159,437 | 33.25M |
| 233 | CTMX | CytomX Therapeutics, Inc. | 318.28M | -1.53% | 1,893,206 | 141.10M |
| 234 | LCTX | Lineage Cell Therapeutics, Inc. | 317.42M | 0.72% | 1,161,079 | 10.91M |
| 235 | ALT | Altimmune, Inc. | 315.08M | -1.65% | 1,991,311 | 20.00K |
| 236 | FDMT | 4D Molecular Therapeutics, Inc. | 311.04M | -0.45% | 421,026 | 33.00K |
| 237 | SCPH | scPharmaceuticals Inc. | 302.68M | 0.18% | 1,223,133 | 49.97M |
| 238 | ALEC | Alector, Inc. | 298.58M | 6.88% | 1,322,262 | 81.13M |
| 239 | RAPT | RAPT Therapeutics, Inc. | 297.68M | 2.10% | 135,890 | - |
| 240 | ALDX | Aldeyra Therapeutics, Inc. | 294.22M | -1.21% | 846,429 | - |
| 241 | GALT | Galectin Therapeutics Inc. | 294.04M | 4.08% | 208,037 | - |
| 242 | LXEO | Lexeo Therapeutics, Inc. | 289.43M | 2.88% | 411,317 | - |
| 243 | ABEO | Abeona Therapeutics Inc. | 289.21M | -0.70% | 1,164,040 | 400.00K |
| 244 | KRRO | Korro Bio, Inc. | 285.30M | -2.44% | 151,104 | 6.28M |
| 245 | TECX | Tectonic Therapeutic, Inc. | 281.80M | -5.93% | 667,501 | - |
| 246 | CAPR | Capricor Therapeutics, Inc. | 277.96M | -2.25% | 663,954 | 13.39M |
| 247 | ANNX | Annexon, Inc. | 276.91M | -4.53% | 1,144,030 | - |
| 248 | OMER | Omeros Corporation | 276.31M | 0.74% | 1,062,297 | - |
| 249 | MREO | Mereo BioPharma Group plc | 275.24M | -1.70% | 965,088 | 500.00K |
| 250 | FHTX | Foghorn Therapeutics Inc. | 271.34M | -2.04% | 103,322 | 24.17M |
| 251 | CADL | Candel Therapeutics, Inc. | 265.69M | -0.21% | 777,913 | - |
| 252 | DBVT | DBV Technologies S.A. | 260.60M | 0.29% | 12,807 | 3.80M |
| 253 | VNDA | Vanda Pharmaceuticals Inc. | 259.40M | -1.57% | 291,578 | 203.47M |
| 254 | NGNE | Neurogene Inc. | 252.76M | 1.55% | 111,334 | 925.00K |
| 255 | ALLO | Allogene Therapeutics, Inc. | 250.73M | -4.24% | 3,179,119 | 22.00K |
| 256 | CBIO | Crescent Biopharma, Inc. | 250.24M | 2.40% | 212,064 | - |
| 257 | TENX | Tenax Therapeutics, Inc. | 249.94M | -0.79% | 78,778 | - |
| 258 | EDIT | Editas Medicine, Inc. | 244.58M | -3.89% | 1,464,840 | 38.90M |
| 259 | ACIU | AC Immune SA | 243.40M | -3.15% | 130,972 | 36.36M |
| 260 | TNXP | Tonix Pharmaceuticals Holding Corp. | 242.90M | 2.18% | 1,455,359 | 9.83M |
| 261 | HUMA | Humacyte, Inc. | 242.31M | -2.55% | 1,891,995 | 818.00K |
| 262 | FENC | Fennec Pharmaceuticals Inc. | 241.30M | -2.03% | 58,558 | 33.30M |
| 263 | CCCC | C4 Therapeutics, Inc. | 240.56M | -0.88% | 1,338,067 | 34.24M |
| 264 | IMMP | Immutep Limited | 239.78M | -1.18% | 33,168 | 3.31M |
| 265 | AARD | Aardvark Therapeutics, Inc. | 238.01M | 6.92% | 154,298 | - |
| 266 | RNAC | Cartesian Therapeutics, Inc. | 237.92M | -4.69% | 93,341 | 1.03M |
| 267 | SLN | Silence Therapeutics plc | 236.64M | 3.30% | 63,495 | 27.17M |
| 268 | LYEL | Lyell Immunopharma, Inc. | 236.49M | -6.88% | 158,415 | 60.00K |
| 269 | VYGR | Voyager Therapeutics, Inc. | 236.30M | 0.24% | 860,890 | 42.58M |
| 270 | NMRA | Neumora Therapeutics, Inc. | 234.82M | -3.33% | 552,509 | - |
| 271 | OABI | OmniAb, Inc. | 233.21M | 0.62% | 540,119 | 23.03M |
| 272 | CLLS | Cellectis S.A. | 231.83M | -2.53% | 62,888 | 63.44M |
| 273 | AVIR | Atea Pharmaceuticals, Inc. | 230.93M | -2.02% | 331,408 | - |
| 274 | JBIO | Jade Biosciences, Inc. | 226.76M | -2.66% | 70,670 | - |
| 275 | IVVD | Invivyd, Inc. | 224.20M | -8.73% | 1,690,035 | 46.21M |
| 276 | HRTX | Heron Therapeutics, Inc. | 221.81M | -2.42% | 1,360,932 | 149.69M |
| 277 | PBYI | Puma Biotechnology, Inc. | 218.61M | -3.98% | 347,488 | 238.06M |
| 278 | PRQR | ProQR Therapeutics N.V. | 217.01M | 3.52% | 327,114 | 20.13M |
| 279 | FBRX | Forte Biosciences, Inc. | 213.28M | -3.00% | 101,304 | - |
| 280 | CDXS | Codexis, Inc. | 212.13M | -5.62% | 565,875 | 57.16M |
| 281 | GNFT | Genfit S.A. | 211.60M | -1.74% | 1,522 | 73.19M |
| 282 | VOR | Vor Biopharma Inc. | 207.97M | -3.18% | 5,531,219 | - |
| 283 | NTHI | NeOnc Technologies Holdings, Inc. | 203.28M | 4.64% | 77,639 | 59.99K |
| 284 | SGMT | Sagimet Biosciences Inc. | 200.01M | -0.81% | 575,150 | - |
| 285 | TNYA | Tenaya Therapeutics, Inc. | 198.83M | -3.17% | 1,680,347 | - |
| 286 | ACRS | Aclaris Therapeutics, Inc. | 196.08M | -1.63% | 675,680 | 16.79M |
| 287 | EPRX | Eupraxia Pharmaceuticals Inc. | 193.95M | 1.50% | 7,570 | - |
| 288 | IPHA | Innate Pharma S.A. | 192.44M | -1.44% | 66,230 | 14.84M |
| 289 | ELTX | Elicio Therapeutics, Inc. | 190.99M | 3.08% | 275,430 | - |
| 290 | MIST | Milestone Pharmaceuticals Inc. | 189.94M | -0.51% | 682,772 | - |
| 291 | KYTX | Kyverna Therapeutics, Inc. | 188.98M | 12.92% | 519,308 | - |
| 292 | TLSA | Tiziana Life Sciences Ltd | 185.03M | -0.60% | 350,342 | - |
| 293 | MDWD | MediWound Ltd. | 181.73M | -2.22% | 104,745 | 19.86M |
| 294 | TRDA | Entrada Therapeutics, Inc. | 180.96M | -0.59% | 840,624 | 79.48M |
| 295 | BDTX | Black Diamond Therapeutics, Inc. | 179.92M | -0.32% | 555,760 | 70.00M |
| 296 | SLS | SELLAS Life Sciences Group, Inc. | 177.95M | 1.20% | 1,892,110 | - |
| 297 | CABA | Cabaletta Bio, Inc. | 175.61M | -3.52% | 2,516,702 | - |
| 298 | TVGN | Tevogen Bio Holdings Inc. | 165.23M | -1.18% | 368,002 | - |
| 299 | VTYX | Ventyx Biosciences, Inc. | 164.72M | -0.86% | 329,312 | - |
| 300 | ENTA | Enanta Pharmaceuticals, Inc. | 161.19M | 1.21% | 219,553 | 64.81M |
| 301 | CRBU | Caribou Biosciences, Inc. | 160.17M | -4.44% | 1,009,641 | 9.12M |
| 302 | ACTU | Actuate Therapeutics, Inc. | 158.62M | -1.70% | 43,573 | - |
| 303 | NVCT | Nuvectis Pharma, Inc. | 157.58M | -0.32% | 63,951 | - |
| 304 | CHRS | Coherus Oncology, Inc. | 156.91M | -0.74% | 1,154,512 | 272.21M |
| 305 | SGMO | Sangamo Therapeutics, Inc. | 154.69M | -0.29% | 3,740,557 | 81.71M |
| 306 | MCRB | Seres Therapeutics, Inc. | 154.17M | 1.21% | 92,963 | - |
| 307 | VTVT | vTv Therapeutics Inc. | 153.62M | 1.23% | 4,834 | 17.00K |
| 308 | THTX | Theratechnologies Inc. | 152.74M | 0.46% | 1,658,121 | 84.38M |
| 309 | GLSI | Greenwich LifeSciences, Inc. | 151.98M | -1.06% | 75,704 | - |
| 310 | ACHV | Achieve Life Sciences, Inc. | 151.27M | -3.90% | 519,150 | - |
| 311 | PLX | Protalix BioTherapeutics, Inc. | 149.10M | -4.10% | 871,504 | 61.95M |
| 312 | AVTX | Avalo Therapeutics, Inc. | 149.02M | 16.09% | 928,024 | 441.00K |
| 313 | GNLX | Genelux Corporation | 146.00M | -4.40% | 171,649 | 8.00K |
| 314 | ELDN | Eledon Pharmaceuticals, Inc. | 145.51M | 2.53% | 585,926 | - |
| 315 | TIL | Instil Bio, Inc. | 145.44M | -6.53% | 299,753 | - |
| 316 | AGEN | Agenus Inc. | 144.98M | 1.79% | 381,304 | 101.71M |
| 317 | CLYM | Climb Bio, Inc. | 143.66M | 5.47% | 567,871 | - |
| 318 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 142.41M | 13.15% | 393,306 | - |
| 319 | CYBN | Cybin Inc. | 141.60M | -0.66% | 499,340 | - |
| 320 | PYXS | Pyxis Oncology, Inc. | 137.06M | 7.80% | 1,321,264 | 2.82M |
| 321 | ACOG | Alpha Cognition Inc. | 136.88M | -2.87% | 82,822 | 4.59M |
| 322 | NKTX | Nkarta, Inc. | 135.66M | -2.05% | 613,018 | - |
| 323 | ONCY | Oncolytics Biotech Inc. | 135.49M | 6.30% | 1,571,964 | - |
| 324 | MOLN | Molecular Partners AG | 134.27M | 3.76% | 170 | 856.30K |
| 325 | CRDF | Cardiff Oncology, Inc. | 133.72M | 0.50% | 504,396 | 545.00K |
| 326 | OBIO | Orchestra BioMed Holdings, Inc. | 132.73M | -2.77% | 151,845 | 2.94M |
| 327 | CGTX | Cognition Therapeutics, Inc. | 129.69M | -8.70% | 3,670,816 | - |
| 328 | CGEN | Compugen Ltd. | 127.21M | -1.45% | 137,744 | 22.14M |
| 329 | ZURA | Zura Bio Limited | 123.53M | -3.06% | 203,157 | - |
| 330 | KALA | KALA BIO, Inc. | 122.66M | -4.64% | 353,380 | - |
| 331 | HURA | TuHURA Biosciences, Inc. | 121.61M | -2.02% | 198,501 | - |
| 332 | SKYE | Skye Bioscience, Inc. | 121.16M | 1.30% | 152,113 | - |
| 333 | SEER | Seer, Inc. | 121.05M | -1.44% | 123,216 | 16.29M |
| 334 | TARA | Protara Therapeutics, Inc. | 116.90M | -1.30% | 103,464 | - |
| 335 | BMEA | Biomea Fusion, Inc. | 116.64M | -2.97% | 667,364 | - |
| 336 | IKT | Inhibikase Therapeutics, Inc. | 116.25M | - | 107,207 | 1.00 |
| 337 | INO | Inovio Pharmaceuticals, Inc. | 115.85M | -4.39% | 1,409,502 | 182.34K |
| 338 | EXOZ | eXoZymes, Inc. | 114.23M | 4.05% | 1,552 | -700.00 |
| 339 | IOBT | IO Biotech, Inc. | 112.66M | -0.58% | 943,491 | - |
| 340 | ANIX | Anixa Biosciences, Inc. | 110.27M | -6.94% | 213,623 | - |
| 341 | FATE | Fate Therapeutics, Inc. | 109.56M | -0.07% | 1,325,580 | 8.47M |
| 342 | ARMP | Armata Pharmaceuticals, Inc. | 107.24M | 2.78% | 13,796 | 6.87M |
| 343 | ATOS | Atossa Therapeutics, Inc. | 107.23M | 0.99% | 495,139 | - |
| 344 | SPRO | Spero Therapeutics, Inc. | 106.92M | - | 148,632 | 48.58M |
| 345 | HLVX | HilleVax, Inc. | 103.45M | - | - | - |
| 346 | ANRO | Alto Neuroscience, Inc. | 103.43M | -3.29% | 69,821 | - |
| 347 | ANEB | Anebulo Pharmaceuticals, Inc. | 102.71M | 0.40% | 93,204 | - |
| 348 | ZNTL | Zentalis Pharmaceuticals, Inc. | 102.43M | - | 550,505 | 26.87M |
| 349 | FBIO | Fortress Biotech, Inc. | 102.36M | 0.29% | 532,083 | 59.30M |
| 350 | SAVA | Cassava Sciences, Inc. | 100.48M | -0.48% | 604,381 | - |
| 351 | ATYR | aTyr Pharma, Inc. | 100.44M | -5.09% | 32,060,142 | 235.00K |
| 352 | PTHS | Pelthos Therapeutics Inc. | 99.45M | 2.09% | 18,345 | - |
| 353 | SRZN | Surrozen, Inc. | 98.99M | -0.09% | 4,932 | 12.62M |
| 354 | MGNX | MacroGenics, Inc. | 96.70M | 4.08% | 780,965 | 165.50M |
| 355 | ADAG | Adagene Inc. | 96.15M | -4.23% | 56,037 | 103.20K |
| 356 | IMA | ImageneBio, Inc. | 93.37M | -2.00% | 20,105 | 4.30M |
| 357 | ORMP | Oramed Pharmaceuticals Inc. | 93.08M | -0.87% | 34,065 | 2.00M |
| 358 | STTK | Shattuck Labs, Inc. | 92.93M | -9.35% | 366,792 | 3.00M |
| 359 | WHWK | Whitehawk Therapeutics, Inc. | 91.90M | - | 395,723 | 21.60M |
| 360 | EQ | Equillium, Inc. | 91.04M | -6.13% | 660,840 | 16.55M |
| 361 | NAUT | Nautilus Biotechnology, Inc. | 91.02M | -3.96% | 369,773 | - |
| 362 | TCRX | TScan Therapeutics, Inc. | 90.80M | -6.98% | 310,568 | 6.96M |
| 363 | COYA | Coya Therapeutics, Inc. | 90.48M | -4.59% | 166,508 | 423.45K |
| 364 | IRD | Opus Genetics, Inc. | 90.16M | 2.14% | 213,518 | 15.42M |
| 365 | CNTB | Connect Biopharma Holdings Limited | 89.71M | - | 68,579 | 1.97M |
| 366 | PLRX | Pliant Therapeutics, Inc. | 89.63M | -4.58% | 534,796 | - |
| 367 | VTGN | Vistagen Therapeutics, Inc. | 88.97M | -0.34% | 350,089 | 646.00K |
| 368 | CSBR | Champions Oncology, Inc. | 87.56M | -8.90% | 76,210 | 56.88M |
| 369 | VXRT | Vaxart, Inc. | 86.58M | -2.82% | - | 80.72M |
| 370 | QNCX | Quince Therapeutics, Inc. | 86.48M | -0.62% | 142,360 | - |
| 371 | VANI | Vivani Medical, Inc. | 85.90M | 19.83% | 1,363,769 | - |
| 372 | KLRS | Kalaris Therapeutics, Inc. | 83.04M | -11.38% | 353,103 | - |
| 373 | NTRB | Nutriband Inc. | 83.03M | -3.36% | 12,997 | 2.58M |
| 374 | OVID | Ovid Therapeutics Inc. | 82.49M | 1.75% | 937,026 | 6.65M |
| 375 | IMUX | Immunic, Inc. | 81.85M | 1.80% | 736,903 | - |
| 376 | ATRA | Atara Biotherapeutics, Inc. | 81.40M | 0.70% | 13,734 | 188.67M |
| 377 | XBIT | XBiotech Inc. | 81.40M | -0.74% | 65,214 | - |
| 378 | ENTX | Entera Bio Ltd. | 80.82M | -2.75% | 56,088 | 166.00K |
| 379 | OKYO | OKYO Pharma Limited | 80.11M | 1.43% | 64,913 | - |
| 380 | IFRX | InflaRx N.V. | 79.94M | 3.51% | 657,065 | 191.22K |
| 381 | ATHE | Alterity Therapeutics Limited | 79.76M | 0.45% | 15,210 | 3.57M |
| 382 | CNTX | Context Therapeutics Inc. | 78.49M | 3.21% | 158,359 | - |
| 383 | ABOS | Acumen Pharmaceuticals, Inc. | 75.72M | 1.63% | 153,400 | - |
| 384 | RPTX | Repare Therapeutics Inc. | 74.75M | - | 80,452 | 250.00K |
| 385 | NSRX | Nasus Pharma Ltd. | 73.61M | -0.06% | 22,744 | - |
| 386 | STRO | Sutro Biopharma, Inc. | 72.29M | -4.36% | 531,940 | 104.47M |
| 387 | BYSI | BeyondSpring Inc. | 72.19M | -5.79% | 38,856 | 1.88M |
| 388 | CBUS | Cibus, Inc. | 72.14M | -3.62% | 134,664 | 4.85M |
| 389 | CRVO | CervoMed Inc. | 72.08M | -3.95% | 140,043 | 7.78M |
| 390 | HYFT | MindWalk Holdings Corp. | 71.54M | -2.52% | 1,225,062 | 18.21M |
| 391 | UNCY | Unicycive Therapeutics, Inc. | 71.35M | 1.25% | 373,300 | - |
| 392 | CVM | CEL-SCI Corporation | 70.58M | -7.25% | 287,805 | - |
| 393 | MGX | Metagenomi, Inc. | 70.56M | 2.73% | 549,991 | 33.77M |
| 394 | GUTS | Fractyl Health, Inc. | 70.19M | -2.26% | 733,814 | 17.00K |
| 395 | HYPD | Hyperion DeFi, Inc. | 69.82M | 6.15% | 1,559,771 | 44.44K |
| 396 | OSTX | OS Therapies Incorporated | 69.62M | -0.90% | 232,132 | - |
| 397 | NRXP | NRx Pharmaceuticals, Inc. | 69.41M | -2.01% | 348,023 | - |
| 398 | QNTM | Quantum BioPharma Ltd. | 68.65M | 6.73% | 126,551 | - |
| 399 | XFOR | X4 Pharmaceuticals, Inc. | 68.28M | -5.30% | 665,419 | 32.77M |
| 400 | SLGL | Sol-Gel Technologies Ltd. | 67.83M | 0.83% | 16,187 | 23.93M |
| 401 | PMVP | PMV Pharmaceuticals, Inc. | 66.24M | 4.17% | 1,511,168 | - |
| 402 | ANL | Adlai Nortye Ltd. | 65.53M | -0.79% | 26,312 | 1.94M |
| 403 | ABVC | ABVC BioPharma, Inc. | 65.24M | 0.70% | 61,453 | 391.24K |
| 404 | INKT | MiNK Therapeutics, Inc. | 64.41M | -2.40% | 32,641 | - |
| 405 | IMMX | Immix Biopharma, Inc. | 64.02M | -2.00% | 127,234 | - |
| 406 | HOWL | Werewolf Therapeutics, Inc. | 64.02M | -3.45% | 186,315 | 1.14M |
| 407 | ACET | Adicet Bio, Inc. | 63.29M | -6.43% | 257,122 | - |
| 408 | PEPG | PepGen Inc. | 61.34M | -3.61% | 609,158 | - |
| 409 | COEP | Coeptis Therapeutics Holdings, Inc. | 60.74M | 0.80% | 62,573 | 263.56K |
| 410 | ADVM | Adverum Biotechnologies, Inc. | 60.43M | -4.64% | 74,975 | 1.00M |
| 411 | MNOV | MediciNova, Inc. | 59.84M | -2.40% | 17,225 | 134.60K |
| 412 | APLT | Applied Therapeutics, Inc. | 59.23M | -4.35% | 978,785 | 121.00K |
| 413 | PRLD | Prelude Therapeutics Incorporated | 58.86M | -10.34% | 99,720 | 7.00M |
| 414 | CELU | Celularity Inc. | 57.39M | - | 305,064 | 44.59M |
| 415 | BTAI | BioXcel Therapeutics, Inc. | 56.98M | -3.01% | 1,320,987 | 868.00K |
| 416 | GANX | Gain Therapeutics, Inc. | 56.80M | -3.07% | 414,292 | - |
| 417 | ALGS | Aligos Therapeutics, Inc. | 56.72M | 3.02% | 39,316 | 3.17M |
| 418 | GNTA | Genenta Science S.p.A. | 56.70M | 0.32% | 6,334 | - |
| 419 | ALXO | ALX Oncology Holdings Inc. | 56.23M | -2.78% | 415,570 | - |
| 420 | ARTV | Artiva Biotherapeutics, Inc. | 55.69M | -3.80% | 107,790 | 251.00K |
| 421 | CUE | Cue Biopharma, Inc. | 55.51M | -2.79% | 84,887 | 8.29M |
| 422 | PDSB | PDS Biotechnology Corporation | 54.08M | -4.17% | 331,584 | - |
| 423 | RADX | Radiopharm Theranostics Limited | 53.61M | 1.43% | 38,221 | 8.79M |
| 424 | DTIL | Precision BioSciences, Inc. | 53.40M | -3.00% | 76,483 | 1.26M |
| 425 | PYPD | PolyPid Ltd. | 52.75M | -1.75% | 20,012 | - |
| 426 | KPTI | Karyopharm Therapeutics Inc. | 52.72M | -2.88% | 51,247 | 137.27M |
| 427 | CAMP | Camp4 Therapeutics Corporation | 52.22M | -6.50% | 116,075 | 3.01M |
| 428 | JUNS | Jupiter Neurosciences, Inc. | 51.90M | -0.67% | 93,729 | - |
| 429 | ICCC | ImmuCell Corporation | 51.11M | -4.24% | 1,308 | 28.27M |
| 430 | MAIA | MAIA Biotechnology, Inc. | 50.81M | -4.35% | 224,375 | - |
| 431 | INMB | INmune Bio, Inc. | 50.78M | -4.02% | 578,781 | 50.00K |
| 432 | ATNM | Actinium Pharmaceuticals, Inc. | 50.23M | -3.01% | 78,984 | 81.00K |
| 433 | RLMD | Relmada Therapeutics, Inc. | 50.12M | -5.63% | 268,517 | - |
| 434 | VERU | Veru Inc. | 50.10M | -7.07% | 109,435 | 16.89M |
| 435 | ACRV | Acrivon Therapeutics, Inc. | 49.07M | 0.65% | 889,600 | - |
| 436 | SER | Serina Therapeutics, Inc. | 48.38M | -6.16% | 28,654 | 130.00K |
| 437 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 48.20M | 8.95% | 2,839,856 | 1.00M |
| 438 | OTLK | Outlook Therapeutics, Inc. | 45.31M | -5.56% | 1,270,296 | 1.51M |
| 439 | ANVS | Annovis Bio, Inc. | 45.21M | -2.11% | 79,122 | - |
| 440 | FGEN | FibroGen, Inc. | 45.05M | -3.21% | 25,110 | 7.35M |
| 441 | CALC | CalciMedica, Inc. | 44.71M | 2.73% | 83,823 | - |
| 442 | RNXT | RenovoRx, Inc. | 44.71M | -3.17% | 483,241 | 662.00K |
| 443 | BRNS | Barinthus Biotherapeutics plc | 43.57M | 1.90% | 67,259 | 14.97M |
| 444 | ESLA | Estrella Immunopharma, Inc. | 43.37M | 4.46% | 47,512 | - |
| 445 | TELO | Telomir Pharmaceuticals, Inc. | 42.93M | 2.31% | 260,872 | - |
| 446 | TPST | Tempest Therapeutics, Inc. | 42.54M | -4.87% | 37,522 | - |
| 447 | IPSC | Century Therapeutics, Inc. | 42.49M | 0.43% | 149,750 | 114.13M |
| 448 | GRCE | Grace Therapeutics, Inc. | 42.32M | -0.97% | 60,740 | - |
| 449 | LTRN | Lantern Pharma Inc. | 42.23M | -4.63% | 152,114 | - |
| 450 | VRCA | Verrica Pharmaceuticals Inc. | 41.66M | - | 56,167 | 14.70M |
| 451 | LIMN | Liminatus Pharma, Inc. | 41.36M | -11.17% | 641,945 | - |
| 452 | PSTV | Plus Therapeutics, Inc. | 41.35M | -2.00% | 3,341,133 | 5.32M |
| 453 | BCAB | BioAtla, Inc. | 39.77M | -6.22% | 595,834 | 11.00M |
| 454 | APLM | Apollomics, Inc. | 39.56M | 51.34% | 682,277 | 198.00K |
| 455 | LVTX | LAVA Therapeutics N.V. | 39.46M | -0.66% | 713,019 | 4.99M |
| 456 | XLO | Xilio Therapeutics, Inc. | 39.06M | -1.58% | 197,097 | 15.00M |
| 457 | GBIO | Generation Bio Co. | 38.86M | -3.03% | 30,930 | 21.23M |
| 458 | RENB | Lunai Bioworks Inc. | 38.08M | -9.89% | 2,897,117 | - |
| 459 | JSPR | Jasper Therapeutics, Inc. | 37.87M | -4.12% | 166,817 | - |
| 460 | IGC | IGC Pharma, Inc. | 37.19M | -4.86% | 373,843 | 1.33M |
| 461 | PLUR | Pluri Inc. | 37.00M | -3.85% | 11,584 | 1.34M |
| 462 | DYAI | Dyadic International, Inc. | 36.19M | 0.93% | 270,589 | 4.14M |
| 463 | MURA | Mural Oncology plc | 36.04M | 0.48% | 199,987 | - |
| 464 | SNTI | Senti Biosciences, Inc. | 35.84M | -1.44% | 45,145 | - |
| 465 | MRSN | Mersana Therapeutics, Inc. | 35.68M | -0.83% | 67,443 | 34.77M |
| 466 | ANTX | AN2 Therapeutics, Inc. | 35.25M | 1.17% | 100,775 | - |
| 467 | KLTO | Klotho Neurosciences, Inc. | 34.98M | -3.47% | 1,144,381 | - |
| 468 | KAPA | Kairos Pharma, Ltd. | 34.85M | 4.35% | 1,383,076 | - |
| 469 | RANI | Rani Therapeutics Holdings, Inc. | 33.81M | -5.73% | 219,013 | 1.20M |
| 470 | CLGN | CollPlant Biotechnologies Ltd. | 33.32M | 1.50% | 7,950 | 2.40M |
| 471 | LSB | LakeShore Biopharma Co., Ltd | 33.03M | -0.68% | 8,438 | 84.75M |
| 472 | OKUR | OnKure Therapeutics, Inc. | 32.34M | 0.84% | 22,706 | - |
| 473 | ITRM | Iterum Therapeutics plc | 29.92M | -1.35% | 467,885 | - |
| 474 | NRSN | NeuroSense Therapeutics Ltd. | 29.55M | 0.85% | 170,718 | - |
| 475 | CASI | CASI Pharmaceuticals, Inc. | 29.51M | -5.22% | 68,079 | 31.56M |
| 476 | PPCB | Propanc Biopharma, Inc. | 28.20M | -0.90% | 795,147 | - |
| 477 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 27.49M | 2.02% | 2,384,261 | - |
| 478 | KZR | Kezar Life Sciences, Inc. | 27.39M | -0.27% | 16,967 | - |
| 479 | DARE | Daré Bioscience, Inc. | 27.02M | -2.15% | 84,388 | -17.70K |
| 480 | SABS | SAB Biotherapeutics, Inc. | 26.86M | 20.00% | 1,895,667 | 114.70K |
| 481 | RNTX | Rein Therapeutics Inc. | 26.80M | - | 301,859 | - |
| 482 | AKTX | Akari Therapeutics, Plc | 25.88M | 5.11% | 3,429,799 | - |
| 483 | CVKD | Cadrenal Therapeutics, Inc. | 25.87M | -5.32% | 15,138 | - |
| 484 | LIXT | Lixte Biotechnology Holdings, Inc. | 25.68M | - | 37,742 | - |
| 485 | MTVA | MetaVia Inc. | 25.65M | -20.30% | 1,593,811 | - |
| 486 | BOLD | Boundless Bio, Inc. | 25.52M | -0.87% | 29,031 | - |
| 487 | NRXS | NeurAxis, Inc. | 25.27M | 5.35% | 63,626 | 3.22M |
| 488 | ENLV | Enlivex Therapeutics Ltd. | 25.05M | -2.78% | 134,880 | - |
| 489 | ICU | SeaStar Medical Holding Corporation | 24.07M | -2.56% | 1,375,752 | 766.00K |
| 490 | RLYB | Rallybio Corporation | 23.76M | -5.22% | 178,535 | 761.00K |
| 491 | LEXX | Lexaria Bioscience Corp. | 23.67M | -17.12% | 453,323 | 615.92K |
| 492 | PMN | ProMIS Neurosciences, Inc. | 23.57M | 7.31% | 903,759 | - |
| 493 | NNVC | NanoViricides, Inc. | 23.14M | -0.69% | 169,853 | - |
| 494 | HOTH | Hoth Therapeutics, Inc. | 23.14M | -4.64% | 1,245,551 | - |
| 495 | XCUR | Exicure, Inc. | 22.43M | -11.25% | 27,071 | 500.00K |
| 496 | PASG | Passage Bio, Inc. | 22.35M | -3.30% | 22,886 | - |
| 497 | ASBP | Aspire Biopharma Holdings, Inc. | 22.29M | 1.06% | 324,451 | - |
| 498 | FBLG | FibroBiologics, Inc. | 22.01M | -0.77% | 249,748 | - |
| 499 | QTTB | Q32 Bio Inc. | 21.83M | -4.79% | 40,828 | - |
| 500 | GDTC | CytoMed Therapeutics Limited | 21.70M | -2.59% | 25,686 | 368.84K |
| 501 | ADAP | Adaptimmune Therapeutics plc | 21.42M | -1.22% | 70,086,588 | 65.09M |
| 502 | CRIS | Curis, Inc. | 20.87M | -2.34% | 48,232 | 11.41M |
| 503 | CING | Cingulate Inc. | 20.74M | -5.85% | 488,920 | - |
| 504 | CTXR | Citius Pharmaceuticals, Inc. | 20.07M | 0.85% | 194,790 | - |
| 505 | SYBX | Synlogic, Inc. | 20.01M | -1.72% | 13,077 | 8.00K |
| 506 | NEUP | Neuphoria Therapeutics Inc. | 19.98M | -15.03% | 92,160 | 15.66M |
| 507 | LSTA | Lisata Therapeutics, Inc. | 19.96M | -0.87% | 11,751 | 1.07M |
| 508 | CLSD | Clearside Biomedical, Inc. | 18.89M | 1.12% | 88,857 | 4.17M |
| 509 | ALLR | Allarity Therapeutics, Inc. | 18.78M | -3.29% | 495,625 | - |
| 510 | EVAX | Evaxion A/S | 18.48M | -0.51% | 52,733 | 3.18M |
| 511 | PULM | Pulmatrix, Inc. | 17.86M | -3.93% | 12,777 | 369.00K |
| 512 | GOVX | GeoVax Labs, Inc. | 17.24M | -2.48% | 555,198 | 6.14M |
| 513 | EDSA | Edesa Biotech, Inc. | 16.82M | -2.85% | 10,092 | - |
| 514 | IBIO | iBio, Inc. | 16.57M | -2.48% | 346,562 | 400.00K |
| 515 | CLRB | Cellectar Biosciences, Inc. | 16.15M | -1.36% | 47,583 | - |
| 516 | BLRX | BioLineRx Ltd. | 16.06M | -3.34% | 20,631 | 17.25M |
| 517 | COCP | Cocrystal Pharma, Inc. | 15.84M | -7.95% | 787,035 | - |
| 518 | LGVN | Longeveron Inc. | 15.82M | 0.21% | 277,412 | 2.07M |
| 519 | ABP | Abpro Holdings, Inc. | 15.47M | 6.10% | 3,189,801 | 183.00K |
| 520 | LPCN | Lipocine Inc. | 15.44M | -3.39% | 17,976 | 4.21M |
| 521 | OSRH | OSR Holdings, Inc. | 15.15M | -4.70% | 223,721 | 104.74K |
| 522 | BCTX | BriaCell Therapeutics Corp. | 15.11M | 5.24% | 138,666 | - |
| 523 | NERV | Minerva Neurosciences, Inc. | 14.97M | -0.93% | 29,812 | - |
| 524 | ATHA | Athira Pharma, Inc. | 14.91M | -0.97% | 162,057 | - |
| 525 | NXTC | NextCure, Inc. | 14.85M | -2.12% | 3,571 | - |
| 526 | THAR | Tharimmune, Inc. | 14.76M | -6.94% | 747,300 | - |
| 527 | MBRX | Moleculin Biotech, Inc. | 14.47M | 5.18% | 2,396,366 | - |
| 528 | CANF | Can-Fite BioPharma Ltd. | 14.16M | -0.08% | 163,043 | 560.00K |
| 529 | TRAW | Traws Pharma, Inc. | 14.06M | -2.93% | 57,256 | 2.90M |
| 530 | BIVI | BioVie Inc. | 13.71M | -0.82% | 258,984 | - |
| 531 | CMMB | Chemomab Therapeutics Ltd. | 13.55M | -6.43% | 121,414 | - |
| 532 | CARM | Carisma Therapeutics, Inc. | 13.13M | -6.63% | 601,561 | 10.77M |
| 533 | LPTX | Leap Therapeutics, Inc. | 12.97M | -1.42% | 230,490 | - |
| 534 | PHGE | BiomX Inc. | 12.92M | 0.10% | 191,026 | - |
| 535 | IMRN | Immuron Limited | 12.88M | -1.64% | 37,929 | 4.78M |
| 536 | APM | Aptorum Group Limited | 12.86M | -2.70% | 89,117 | - |
| 537 | IMNN | Imunon, Inc. | 12.71M | -7.01% | 104,763 | - |
| 538 | MRKR | Marker Therapeutics, Inc. | 12.30M | -4.47% | 167,009 | 5.39M |
| 539 | PHIO | Phio Pharmaceuticals Corp. | 12.08M | -2.31% | 53,003 | - |
| 540 | SNGX | Soligenix, Inc. | 12.04M | 0.72% | 59,231 | 2.34K |
| 541 | INTS | Intensity Therapeutics, Inc. | 11.87M | 0.83% | 1,460,610 | - |
| 542 | MBIO | Mustang Bio, Inc. | 11.65M | 1.90% | 134,850 | - |
| 543 | PLRZ | Polyrizon Ltd. | 11.52M | -8.11% | 658,608 | - |
| 544 | BRTX | BioRestorative Therapies, Inc. | 11.41M | -3.38% | 68,914 | 605.20K |
| 545 | SNSE | Sensei Biotherapeutics, Inc. | 11.35M | 1.12% | 3,683 | - |
| 546 | XTLB | XTL Biopharmaceuticals Ltd. | 10.80M | -1.64% | 4,289 | 451.00K |
| 547 | LYRA | Lyra Therapeutics, Inc. | 10.54M | -0.16% | 22,563 | 770.00K |
| 548 | PCSA | Processa Pharmaceuticals, Inc. | 10.41M | 3.14% | 3,150,828 | - |
| 549 | EVGN | Evogene Ltd. | 10.38M | 0.42% | 89,722 | 9.44M |
| 550 | BOLT | Bolt Biotherapeutics, Inc. | 10.31M | 4.47% | 8,147 | 4.17M |
| 551 | NBY | NovaBay Pharmaceuticals, Inc. | 10.19M | -20.09% | 1,107,007 | 9.78M |
| 552 | GNPX | Genprex, Inc. | 9.99M | -14.31% | 3,781,431 | - |
| 553 | ARTL | Artelo Biosciences, Inc. | 9.92M | -10.07% | 51,483 | - |
| 554 | EPIX | ESSA Pharma Inc. | 9.59M | 4.86% | 1,888,102 | - |
| 555 | RNAZ | TransCode Therapeutics, Inc. | 9.47M | -2.66% | 8,048 | - |
| 556 | VIVS | VivoSim Labs, Inc. | 9.46M | -5.21% | 86,440 | 142.00K |
| 557 | CELZ | Creative Medical Technology Holdings, Inc. | 9.37M | -2.16% | 24,532 | 6.00K |
| 558 | DWTX | Dogwood Therapeutics, Inc. | 9.36M | 0.41% | 13,842 | - |
| 559 | MTNB | Matinas BioPharma Holdings, Inc. | 9.16M | -2.94% | 68,839 | - |
| 560 | KPRX | Kiora Pharmaceuticals, Inc. | 9.10M | 0.57% | 16,642 | 20.00K |
| 561 | INAB | IN8bio, Inc. | 9.08M | -0.99% | 44,960 | - |
| 562 | ERNA | Ernexa Therapeutics Inc. | 9.05M | -5.22% | 1,172,924 | 488.00K |
| 563 | BCDA | BioCardia, Inc. | 8.90M | -9.71% | 653,286 | 3.00K |
| 564 | KZIA | Kazia Therapeutics Limited | 8.88M | -0.87% | 15,946 | 1.55M |
| 565 | APRE | Aprea Therapeutics, Inc. | 8.74M | 3.09% | 27,516 | 841.01K |
| 566 | AEON | AEON Biopharma, Inc. | 8.71M | -4.10% | 31,710 | - |
| 567 | ADXN | Addex Therapeutics Ltd | 8.48M | 15.92% | 14,427 | 278.51K |
| 568 | GLMD | Galmed Pharmaceuticals Ltd. | 8.14M | 0.34% | 64,278 | - |
| 569 | ALZN | Alzamend Neuro, Inc. | 7.85M | -4.58% | 156,016 | - |
| 570 | HCWB | HCW Biologics Inc. | 7.82M | 3.86% | 172,274 | 832.84K |
| 571 | VYNE | VYNE Therapeutics Inc. | 7.75M | -0.62% | 1,352,396 | 476.00K |
| 572 | IBO | Impact BioMedical Inc. | 7.70M | -7.38% | 160,291 | 7.00K |
| 573 | ENTO | Entero Therapeutics, Inc. | 7.59M | 17.73% | 298,393 | - |
| 574 | ADIL | Adial Pharmaceuticals, Inc. | 7.57M | - | 472,689 | - |
| 575 | NCNA | NuCana plc | 7.55M | -10.52% | 423,322 | - |
| 576 | CYCN | Cyclerion Therapeutics, Inc. | 7.46M | -4.74% | 15,186 | 2.17M |
| 577 | PTIX | Protagenic Therapeutics, Inc. | 7.05M | 8.24% | 81,153 | - |
| 578 | TNFA | TNF Pharmaceuticals, Inc. | 6.84M | -2.03% | 299,960 | - |
| 579 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.81M | -0.72% | 11,212 | 19.51K |
| 580 | CERO | CERo Therapeutics Holdings, Inc. | 6.65M | -2.65% | 62,584 | - |
| 581 | SILO | Silo Pharma, Inc. | 6.64M | -3.37% | 1,221,113 | 72.10K |
| 582 | ACXP | Acurx Pharmaceuticals, Inc. | 6.53M | -1.20% | 12,802 | - |
| 583 | NLSP | NLS Pharmaceutics AG | 6.41M | -4.25% | 176,005 | - |
| 584 | PMCB | PharmaCyte Biotech, Inc. | 6.34M | -7.64% | 119,758 | - |
| 585 | CLDI | Calidi Biotherapeutics, Inc. | 6.28M | 1.25% | 133,888 | - |
| 586 | ENSC | Ensysce Biosciences, Inc. | 6.23M | -0.47% | 41,387 | 7.41M |
| 587 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 5.91M | - | 52,906 | 984.49K |
| 588 | TTNP | Titan Pharmaceuticals, Inc. | 5.69M | -1.04% | 11,389 | - |
| 589 | CMND | Clearmind Medicine Inc. | 5.58M | 0.99% | 10,496 | - |
| 590 | KTTA | Pasithea Therapeutics Corp. | 5.36M | -3.22% | 107,593 | - |
| 591 | SPRB | Spruce Biosciences, Inc. | 5.36M | -0.63% | 10,882 | 1.30M |
| 592 | TCRT | Alaunos Therapeutics, Inc. | 5.29M | 3.45% | 16,215 | 6.00K |
| 593 | PALI | Palisade Bio, Inc. | 5.27M | -4.13% | 10,868,971 | - |
| 594 | PPBT | Purple Biotech Ltd | 5.24M | 0.40% | 602,696 | - |
| 595 | OGEN | Oragenics, Inc. | 5.20M | -3.08% | 97,462 | - |
| 596 | CNSP | CNS Pharmaceuticals, Inc. | 5.10M | -2.84% | 25,084 | - |
| 597 | QNRX | Quoin Pharmaceuticals, Ltd. | 5.05M | 4.63% | 1,767,439 | - |
| 598 | XBIO | Xenetic Biosciences, Inc. | 5.04M | 1.08% | 28,603 | 2.45M |
| 599 | ADTX | Aditxt, Inc. | 5.03M | -2.88% | 87,079 | 12.05K |
| 600 | ONCO | Onconetix, Inc. | 4.88M | -3.52% | 24,196 | 1.33M |
| 601 | GRI | GRI Bio, Inc. | 4.83M | -0.52% | 247,942 | - |
| 602 | MLEC | Moolec Science SA | 4.82M | -5.51% | 33,999 | 7.83M |
| 603 | APVO | Aptevo Therapeutics Inc. | 4.64M | -6.00% | 13,254,406 | - |
| 604 | XRTX | XORTX Therapeutics Inc. | 4.47M | -0.57% | 13,466 | - |
| 605 | BDRX | Biodexa Pharmaceuticals Plc | 4.21M | 8.63% | 42,859 | 104.90K |
| 606 | JAGX | Jaguar Health, Inc. | 4.05M | -5.58% | 80,370 | 11.81M |
| 607 | TOVX | Theriva Biologics, Inc. | 3.98M | -0.62% | 604,532 | - |
| 608 | QLGN | Qualigen Therapeutics, Inc. | 3.83M | 13.00% | 3,720,359 | - |
| 609 | DRMA | Dermata Therapeutics, Inc. | 3.80M | -5.58% | 82,204 | - |
| 610 | GLTO | Galecto, Inc. | 3.77M | 3.64% | 82,184 | - |
| 611 | REVB | Revelation Biosciences, Inc. | 3.63M | -1.90% | 370,330 | - |
| 612 | SLRX | Salarius Pharmaceuticals, Inc. | 2.83M | -2.37% | 121,776 | - |
| 613 | GTBP | GT Biopharma, Inc. | 2.81M | -4.34% | 306,026 | - |
| 614 | CDT | CDT Equity Inc. | 2.75M | 40.10% | 195,611,324 | - |
| 615 | AZTR | Azitra, Inc. | 2.75M | -2.60% | 118,906 | 7.50K |
| 616 | VRAX | Virax Biolabs Group Limited | 2.65M | -3.19% | 310,440 | 6.33K |
| 617 | INDP | Indaptus Therapeutics, Inc. | 2.62M | -1.66% | 172,241 | - |
| 618 | ELAB | PMGC Holdings Inc. | 2.42M | - | 24,512 | -605.53K |
| 619 | SCNI | Scinai Immunotherapeutics Ltd. | 2.42M | 1.59% | 48,392 | 1.15M |
| 620 | SPRC | SciSparc Ltd. | 2.39M | 142.93% | 123,201,982 | 1.31M |
| 621 | PBM | Psyence Biomedical Ltd. | 2.17M | -1.85% | 130,237 | - |
| 622 | ENVB | Enveric Biosciences, Inc. | 2.10M | -29.30% | 3,081,543 | - |
| 623 | SLXN | Silexion Therapeutics Corp | 2.00M | 1.13% | 259,803 | - |